Guerbet, Caisse Centrale de Réassurances, L’Occitane and Sopra Steria were among the backers for the life sciences-focused venture firm's BioMedTech fund.

MIT's Taris, which is developing a drug delivery system for bladder diseases, has been purchased by Johnson & Johnson.

Bristol-Myers Squibb has exited Taris, which is developing a drug delivery system for bladder diseases, in a purchase by Johnson & Johnson.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis, Merck & Co and Eli Lilly-backed Forma Therapeutics, which is working on treatments for rare haematologic diseases and cancers, has added $100m to its coffers.

BioMedTech will work to establish approximately a dozen spinouts from European and American universities, with a particular focus on France.

Paige.ai, a Memorial Sloan Kettering spinout, has obtained more than $70m to date and will use the series B to expand its market presence and product line.

Rev1 Catalyst Fund II will fund startups generated through research by Nationwide Children’s Hospital, which has also backed the vehicle.

Cogitativo, developer of a data analysis platform for healthcare, has closed an $18.5m round led by Wells Fargo Strategic Capital.